Cargando…
Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity
Purpose. To describe the distribution of ocular variables, risk factors, and disease severity in newly diagnosed ocular hypertension (OH) or open-angle glaucoma (OAG). Methods. Eligible subjects underwent a complete history and examination. Adjusted odds ratios (ORs) and 95% confidence intervals (CI...
Autores principales: | Buys, Yvonne M., Harasymowycz, Paul, Gaspo, Rania, Kwok, Kenneth, Hutnik, Cindy M. L., Blondeau, Pierre, Birt, Catherine M., Piemontesi, Robert L. G., Gould, Lisa F., Lesk, Mark R., Ahmed, Iqbal K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159007/ https://www.ncbi.nlm.nih.gov/pubmed/21869921 http://dx.doi.org/10.1155/2012/757106 |
Ejemplares similares
-
Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis
por: Harasymowycz, Paul, et al.
Publicado: (2021) -
Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
por: Harasymowycz, Paul, et al.
Publicado: (2016) -
Tolerability and effectiveness of preservative-free dorzolamide–timolol (preservative-free COSOPT(®)) in patients with open-angle glaucoma or ocular hypertension
por: Hutnik, Cindy, et al.
Publicado: (2010) -
The Association Between Ocular Rigidity and Neuroretinal Damage in Glaucoma
por: Sayah, Diane N., et al.
Publicado: (2020) -
An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
por: Nixon, Donald R, et al.
Publicado: (2012)